OUTCOMES IN TREATMENT OF EUROPEAN (EU) PATIENTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (CABP) COMPARING DELAFLOXACIN (DLX) AND MOXIFLOXACIN (MOX)
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI